Waddah Maskoun is a Cardiology physician affiliated with Henry Ford Health. OpenAlex indexes 85 publications with 1,133 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Adaptive Cardiac Resynchronization Therapy in Patients With RBBB
Sponsor: Henry Ford Health System
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MedtronicProgram year20254 paymentsResearch$28,555openpaymentsdata.cms.gov ↗
- BIOTRONIK INC.Program year202513 payments
- Medtronic, Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
74.6%Antiarrhythmic41.2%Amiodarone Hcl40%Dofetilide34%Mexiletine Hcl15%Flecainide Acetate7%Quinidine Gluconate5%Part D<11 patientsBeta blocker28.1%Metoprolol Succinate52%Metoprolol Tartrate31%Sotalol17%Part D≥31 patients+ 1 more class in this area
Blood & clotting
22.5%Factor Xa inhibitor22.5%Eliquis100%Part D≥48 patientsMetabolism & gastrointestinal
2.9%Potassium supplement2.9%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Right Ventricular Endocardial Versus Epicardial Leads on Outcomes in Patients With Tricuspid Valve Prosthesis
Journal of Cardiovascular Electrophysiology
2026 - Antimicrobial Pocket Flush and Cardiac Implantable Electronic Device Infection: Meta‐Analysis of Real‐World Studies
Pacing and Clinical Electrophysiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Philip, MD
Henry Ford Health
David Lanfear, MD
Henry Ford Health
David Ozog, MD
Henry Ford Health
Jessica Mellinger, MD
Henry Ford Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”